Rivanna Medical
  • Products
    • ProductsAccuro
    • Consumables
  • Resources
    • TrainingTraining
    • Testimonials
    • Clinical Value
    • Articles & Press
    • Upgrade
  • About
    • AboutRIVANNA
    • Leadership & BOD
    • Careers
  • Contact
    • ContactContact Us
    • Return Policy
  • Get Quote
Select Page

BARDA awards nearly $10 million to RIVANNA to accelerate development of CADe/x AI module for Accuro XV

by RIVANNA | Jul 28, 2025 | Press Releases

CHARLOTTESVILLE, VA – JULY 28, 2025 – RIVANNA®, developer of imaging-based medical technologies, announced that it received $9.92 million in federal funding of a contractual option from the Biomedical Advanced Research and Development Authority (BARDA), part of the...

RIVANNA’s next-generation ultrasound guidance platform and AI-driven imaging software receive FDA 510(K) clearance

by RIVANNA | Jul 15, 2025 | Press Releases

CHARLOTTESVILLE, VA – JULY 15, 2025 – RIVANNA®, developer of world-first imaging-based medical technologies, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) regarding the Accuro® 3S diagnostic ultrasound system and...
Building a Health System to Support Aging Populations [6 Steps]

Building a Health System to Support Aging Populations [6 Steps]

by RIVANNA | Jun 29, 2025 | News

There is a significant shift occurring in the demographic composition of many developed countries: the aging of their populations. For the healthcare sector in the U.S., this presents a major challenge as a larger number of elderly people will need medical care....
Some Studies Show Up to 25% Fewer Assisted Deliveries With Low-Dose Epidurals

Some Studies Show Up to 25% Fewer Assisted Deliveries With Low-Dose Epidurals

by RIVANNA | Jun 10, 2025 | News

The management of labor pain has always walked a fine line between efficacy and impact on mobility. Traditional epidural techniques, while effective in pain relief, often result in significant motor block that limits maternal movement. This issue is increasingly at...

RIVANNA selected for prestigious MedTech Innovator 2025 Accelerator Cohort

by RIVANNA | Jun 9, 2025 | Press Releases

— One of 65 startups chosen from nearly 1,500 global applicants — — Selected to participate in the world’s leading medtech accelerator — Charlottesville, VA, USA — June 9, 2025 — RIVANNA®, a medical device innovator and manufacturer focused on imaging-based medical...
« Older Entries
Next Entries »

Recent Posts

  • Using AI to Strengthen Clinical Confidence: RIVANNA’s Will Mauldin on the Outcomes Rocket Podcast
  • RIVANNA Receives FDA 510(k) Clearance for Accuro XV Musculoskeletal Ultrasound Imaging System
  • RIVANNA nominated for MedTech Scale-Up of the Year at MedTech World Awards 2026 | North America
  • RIVANNA’s Accuro XV Demonstrates Feasibility of Musculoskeletal Imaging by Non-physician Users With Minimal Training
  • RIVANNA expands multi-site clinical study for Accuro XV musculoskeletal imaging system

Products


Accuro
Accuro 3S
Accessories
Consumables
True-View Phantoms

Resources


Clinical Evidence
Testimonial
Accuro Academy
Articles & Press
True-View Phantoms

Resources


Product Documents
Service & Warranty
Software Updates
Contact Us

About

RIVANNA
Technology
Mission, Vision, & Values
Leadership, BOD, & Advisory
Careers

  • Facebook
  • X
  • YouTube
  • LinkedIn
  • Instagram
Designed by ProvenContent.com © 2026 RIVANNA MEDICAL | 2400 HUNTERS WAY | CHARLOTTESVILLE, VA 22911